Comparative Guide
Patent Litigation
United States
Bijal Vakil, Steven Reichel, Lexi Ma, Mason Seden-Hansen & Sandeep Stanley
Skadden, Arps, Slate, Meagher & Flom LLP advises life sciences clients on major M&A, with notable strength in acquisitions and dispositions, corporate restructurings, and joint ventures. The firm also handles litigation related to Medicaid, Medicare and insurance fraud, the False Claims Act, mass torts, and securities, as well as Congressional investigations under the Foreign Corrupt Practices Act. On the regulatory side, it provides FDA regulatory diligence in connection with acquisitions, divestitures, financing, and investments, along with guidance on compliance and corporate governance. Laura Knoll has left the firm.
L'éditorial du Legal 500
Distinctions
La satisfaction du client: Qualité de l’avocat et de l’équipe
La satisfaction du client: Facturation et efficacité
La satisfaction du client: Connaissance du secteur
Clients clés
- Ambrx Biopharma, Inc.
- Aspen Technology, Inc.
- Catalent, Inc.
- Centerview Partners LLC
- Endo Pharmaceuticals
- EngageSmart
- Eyebiotech Limited
- Intercept Pharmaceuticals, Inc.
- International Flavors & Fragrances Inc.
- Lazard Frères & Co. LLC
- MedStar Health, Inc.
- Mirati Therapeutics, Inc.
- MorphoSys AG
- Permira Advisers LLC
- POINT Biopharma
- Purdue Pharma L.P.
- R1 RCM Inc.
- Vertex Pharmaceuticals
Points forts
Represented a special committee of the board of directors of R1 RCM Inc. in its acquisition by investment funds at an enterprise value of $8.9 billion.
Advised Mirati Therapeutics, Inc. on its acquisition by Bristol Myers Squibb (BMS), which is now a wholly owned subsidiary of the company for a total equity value of $4.8 billion.
Advised Vertex Pharmaceuticals on its $4.9 billion acquisition of Alpine Immune Sciences.
Autres avocats clés
Resa Schlossberg